Argelia E. Rojas-Mayorquín

Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease

Rui Daniel Prediger, Aderbal S. Aguiar, Argelia E. Rojas-Mayorquín et al. · Neurotoxicity Research · 2009 · 127 citations

Neurodegenerative Diseases, Medicine, Parkinson ’ +7

Modulation of PPAR-<i>γ</i>by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases

Daniel Ortuño‐Sahagún, Ana Laura Márquez-Aguirre, Saray Quintero-Fabián et al. · PPAR Research · 2012 · 51 citations · Full text

Nutrition, Oxidative Stress, Obesity +22

Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson’s disease

Rui Daniel Prediger, Argelia E. Rojas-Mayorquín, Aderbal S. Aguiar et al. · Journal of Neural Transmission · 2011 · 40 citations · Full text

Knockout Mouse, Neurodegenerative Diseases, Developmental Biology +6

Microarray analysis of striatal embryonic stem cells induced to differentiate by ensheathing cell conditioned media

Argelia E. Rojas-Mayorquín, Nadia Magali Torres‐Ruíz, Daniel Ortuño‐Sahagún et al. · Developmental Dynamics · 2008 · 30 citations

Pleiotrophin receptor RPTP‐ζ/β expression is up‐regulated by <scp>l</scp>‐DOPA in striatal medium spiny neurons of parkinsonian rats

Juan E. Ferrario, Argelia E. Rojas-Mayorquín, Marisa Saldaña-Ortega et al. · Journal of Neurochemistry · 2008 · 24 citations